9 independently sourced, verified trend briefs about this subject.
Newsylist includes a story here only after at least four independent sources support it and its brief passes the verification check. The qualifying coverage spans 4 news categories, from Jun 23, 2026 through Jul 22, 2026.
The cards below are ordered newest first. Each opens the underlying timeline, source list, coverage velocity and verification context; raw or extractive-only records are excluded.
Engineers at MIT have developed a new method for growing artificial blood vessels using magnetic fields and mechanical stretching.
De-extinction startup Colossal Biosciences is reportedly targeting a valuation between $20 billion and $30 billion in a new funding round.
Scientists have unlocked a biotechnology shortcut allowing plant seeds to produce bovine casein, a key milk protein, without the need for cows.
New brain-shuttle biologics are overcoming the blood-brain barrier to deliver critical treatments for Alzheimer's and cancer.
Researchers and investors are evaluating new clinical data from Biogen as the firm explores tau-targeting treatments for Alzheimer’s disease.
A growing divide in the brain-computer interface market pits surgical implants against non-invasive wearable technology.
An AI biotech firm has acquired Novo's Parkinson's stem cell therapy following promising data from initial human trials.
Novartis is expanding its cancer-drug pipeline through the acquisition of U.K.-based biotech firm Myricx Bio in a deal valued up to $1.5 billion.
The U.S. Department of Health and Human Services is launching a department-wide effort to accelerate clinical trials and restore American leadership in medical research.